A novel approach for boosting antimicrobial peptides through end-tagging with hydrophobic oligopeptide stretches is demonstrated. Focusing on two peptides derived from kininogen, GKHKNKGKKNGKHNGWK (GKH17) and HKHGHGHGKHKNKGKKN (HKH17), tagging resulted in enhanced killing of Gram-positive Staphylococcus aureus, Gramnegative Escherichia coli, and fungal Candida albicans. Microbicidal potency increased with tag length, also in serum, and was larger for W and F stretches than for aliphatic ones. The enhanced microbicidal effects correlated to a higher degree of bacterial wall rupture. Analogously, tagging promoted peptide binding to model phospholipid membranes and liposome rupture, particularly for anionic and cholesterol-void membranes. Tagged peptides displayed low toxicity, particularly in the presence of serum, and resisted degradation by human leukocyte elastase, and staphylococcal aureolysin and V8 proteinase. The biological relevance of these findings was demonstrated ex vivo and in vivo in porcine S. aureus skin infection models. The generality of end-tagging for facile boosting of antimicrobial peptides without the need for post-synthesis modification was also demonstrated.
A novel approach for boosting antimicrobial peptides through end-tagging with hydrophobic oligopeptide stretches is demonstrated. Focusing on two peptides derived from kininogen, GKHKNKGKKNGKHNGWK (GKH17) and HKHGHGHGKHKNKGKKN (HKH17), tagging resulted in enhanced killing of Gram-positive Staphylococcus aureus, Gramnegative Escherichia coli, and fungal Candida albicans. Microbicidal potency increased with tag length, also in serum, and was larger for W and F stretches than for aliphatic ones. The enhanced microbicidal effects correlated to a higher degree of bacterial wall rupture. Analogously, tagging promoted peptide binding to model phospholipid membranes and liposome rupture, particularly for anionic and cholesterol-void membranes. Tagged peptides displayed low toxicity, particularly in the presence of serum, and resisted degradation by human leukocyte elastase, and staphylococcal aureolysin and V8 proteinase. The biological relevance of these findings was demonstrated ex vivo and in vivo in porcine S. aureus skin infection models. The generality of end-tagging for facile boosting of antimicrobial peptides without the need for post-synthesis modification was also demonstrated.
Due to increasing bacterial resistance, there is a need for new types of antibiotics (1) . Antimicrobial peptides (AMPs) are interesting in this context since they provide rapid and broadspectrum response towards both Gram-negative and Gram-positive bacteria, as well as fungi (2) (3) (4) (5) (6) (7) (8) , at seemingly limited resistance development (6) . Although there is increasing evidence that AMPs influence bacteria in a multitude of ways (5) , as well as a considerable diversity among the 900 AMPs presently known (http://www.bbcm.univ.trieste.it/~tossi/search.ht m), bacterial wall rupture plays a key role in the bactericidal action of most AMPs. From a therapeutic perspective, AMPs should ideally rupture bacterial walls specifically, leaving (human) eukaryotic cells unaffected. Approaches for reaching this include, e.g., QSAR in combination with directed amino acid modifications (9) (10) (11) (12) , and identification of selective AMPs generated through infectionrelated proteolysis of endogenous proteins (13) (14) (15) .
From a mechanistic perspective, high AMP adsorption is a prerequisite for potent membrane disruption, which scales with the amount AMP bound to the lipid membrane (16) (17) (18) (19) . Although high AMP adsorption can sometimes be reached by highly charged and hydrophilic AMPs, Staphylococcus aureus and other important pathogens have a relatively low electrostatic surface potential, which may be reduced or even reversed, e.g., by L-lysine modification of phosphatidylglycerol, D-alanine modification of cell wall teichoic acid, and aminoarabinose modifications in LPS, reducing AMP binding to Gram-positive and Gram-negative bacteria, respectively (6) . Furthermore, electrostatic AMP binding is salt sensitive, and bactericidal consisting of 0.03% (w/v) TSB, 1% (w/v) low electroendosmosis type (EEO) agarose (SigmaAldrich, St. Louis, USA) and 0.02% (v/v) Tween 20 (Sigma-Aldrich, St. Louis, USA). The underlay was poured into a Ø 144 mm petri dish. After agarose solidification, 4 mmdiameter wells were punched and 6 µl peptide solution of required concentration added to each well. Plates were incubated at 37ºC for 3 hours to allow peptide diffusion. The underlay gel was then covered with 15 ml of molten overlay (6% TSB and 1% Low-EEO agarose in distilled H 2 O). Antimicrobial activity of a peptide was visualized as a zone of clearing around each well after 18-24 hours of incubation at 37°C.
Minimal inhibitory concentration assay (MIC) -MIC assay was carried out by a microtiter broth dilution method as previously described (11, 29) with slight modifications. For preparation of refined media, 100 ml Luria Bertani broth was prepared in 10 mM Tris, pH 7.4, and applied to a column packed with 40 ml DEAE Sephacel (9013-34-7; Sigma-Aldrich, St. Louis, USA). The column was previously rinsed 2 times the bed volume with water, 2 M NaCl, 0.1 M NaOH, water, and 70 % ethanol, respectively, and finally equilibrated in 10 mM Tris (pH 7.4) before use. The medium was passed through the column twice and finally sterilized by filtration (Millex GP filter unit 0.22 µM) and stored at 8°C until use. For determination of MIC, peptides were dissolved in 10 mM Tris, pH 7.4, at a concentration 10 times higher than the required range by serial dilutions from a stock solution. Ten µl of each concentration was added to each corresponding well of a 96-well microtiter plate (polypropylene, Costar Corp., Cambridge, USA). Bacteria grown over night in 3 % TSB were rinsed with Tris, pH 7.4, and diluted in refined LB medium to a concentration of ~1x10 5 CFU/ml. Ninety µl of bacterial solution in the refined LB medium was added to each well containing the test peptides. The plate was incubated at 37 °C overnight. MIC was taken as the concentration at which > 90% of growth inhibition was observed.
Protease sensitivity assay -Peptides (1 µg) were incubated at 37 °C with S. aureus aureolysin (0.1 µg, 25000 units/mg), S. aureus V8 proteinase (0.1 µg, 2000 mU), both from BioCol µGmbH (Potsdam, Germany), or neutrophil elastase (0.4 µg, 29 units/mg; Calbiochem (La Jolla, USA)) in a total volume of 30 µl for 3 hours. The materials were analyzed on 16.5% precast sodium dodecyl sulfate polyacrylamide (SDS-PAGE) Tris-Tricine gels (BioRad, Hercules, USA) and analyzed after staining with Coomassie Blue R-250.
MTT assay -Sterile filtered MTT (3-(4,5-dimethylthiazolyl)-2,5-diphenyl-tetrazolium bromide; Sigma-Aldrich, St. Louis, USA) solution (5 mg/ml in PBS) was stored protected from light at -20°C until usage. HaCaT keratinocytes, 3000 cells/well, were seeded in 96 well plates and grown in keratinocyte-SFM/BPE-rEGF medium to confluence.
Keratinocyte-SFM/BPE-rEGF medium alone, or keratinocyte-SFM supplemented with 20% serum, was added, followed by peptide addition to 60 µM. After incubation over night, 20 µl of the MTT solution was added to each well and the plates incubated for 1 h in CO 2 at 37°C. The MTT-containing medium was then removed by aspiration. The blue formazan product generated was dissolved by addition of 100 µl of DMSO per well, gently swirling the plates for 10 min at room temperature. The absorbance was monitored at 550 nm. Results given represent mean values from triplicate measurements.
Lactate dehydrogenase (LDH) assay -HaCaT keratinocytes were grown in 96 well plates (3000 cells/well) in serum-free keratinocyte medium (SFM) supplemented with bovine pituitary extract and recombinant EGF (BPErEGF) (Invitrogen, Eugene, USA) to confluency. The medium was then removed, and the peptides (at 60 µM, diluted in 200 µl of SFM/BPE-rEGF or keratinocyte-SFM supplemented with 20% human serum) were added. The LDH-based TOX-7 kit (Sigma-Aldrich, St. Louis, USA) was used for quantification of LDH release from the cells. Results represent mean values from triplicate measurements, and are given as fractional LDH release relative to the positive control consisting of 1% Triton X-100 (yielding 100% LDH release).
Hemolysis assay -EDTA-blood was centrifuged at 800 g for 10 min, whereafter plasma and buffy coat were removed. The erythrocytes were washed three times and resuspended in PBS, pH 7.4 to get a 5% suspension. For experiments in 50% blood, EDTA-blood was diluted (1:1) with PBS. The cells were incubated with end-over-end rotation for 1 h at 37°C in the presence of peptides (60 µM). 2% Triton X-100 (Sigma-Aldrich, St. Louis, USA) served as positive control. The samples were then centrifuged at 800 g for 10 min. Hemoglobin release was monitored by absorbance at 540 nm and is expressed as % of TritonX-100 induced hemolysis. Results given represent mean values from triplicate measurements.
Transmission electron microscopy -S. aureus ATCC 29213 bacteria were grown in TH medium at 37ºC to mid-logarithmic phase. The bacteria were washed in buffer (10 mM Tris, pH 7.4, 0.15 M NaCl, 5 mM glucose) and resuspended in the same buffer. Peptides at 30 µM were incubated with S. aureus ATCC 29213 (1×10 8 bacteria) for two hours in a total volume of 50 ml in 10 mM Tris, pH 7.4, 5 mM glucose. Ten µl of the bacterial suspensions were then adsorbed onto carbon-coated copper grids for 1 min, washed briefly by two drops of water, and negatively stained by two drops of 0.75 % uranyl formate. The grids were rendered hydrophilic by glow discharge in low pressure residual air. Specimens were observed in a Jeol JEM 1230 electron microscope operated at 60 kV accelerating voltage, and images recorded with a Gatan Multiscan 791 CCD camera.
Fluorescence microscopy -For monitoring of membrane permeabilization using the impermeant probe FITC (Sigma-Aldrich, St. Louis, USA), S. aureus ATCC 29213 bacteria were grown to mid-logarithmic phase in TSB medium. Bacteria were washed and resuspended in buffer (10 mM Tris, pH 7.4, 0.15M NaCl, 5 mM glucose) to yield a suspension of 1x10 7 CFU/ml. 100 µl of the bacterial suspension was incubated with 30 µM of the respective peptides at 30°C for 30 min. Microorganisms were then immobilized on poly (L-lysine)-coated glass slides by incubation for 45 min at 30°C, followed by addition onto the slides of 200 µl of FITC (6 µg/ml) in buffer and incubation for 30 min at 30°C. The slides were washed and bacteria fixed by incubation, first on ice for 15 min, then in room temperature for 45 min in 4% paraformaldehyde. The glass slides were subsequently mounted on slides using Prolong Gold antifade reagent mounting medium (Invitrogen, Eugene, USA). For fluorescence analysis, bacteria were visualized using a Nikon Eclipse TE300 (Nikon, Melville, USA) inverted fluorescence microscope equipped with a Hamamatsu C4742-95 cooled CCD camera (Hamamatsu, Bridgewater, USA) and a Plan Apochromat ×100 objective (Olympus, Orangeburg, USA). Differential interference contrast (Nomarski) imaging was used for visualization of the microbes themselves.
Viable-count analysis -S. aureus ATCC 29213 bacteria were grown to mid-logarithmic phase in Todd-Hewitt (TH) medium. Following this, bacteria (50 ml; 2×10 6 CFU/ml) were incubated, at 37°C for 2 hours, with GKH17, HKH17, their tagged variant peptides, or LL-37 (at 0.1, 0.5, 1.0, 5, 10, 50, and 100 µM) in 10 mM Tris, 0.15 M NaCl, with or without 20% human citrate-plasma. To quantify bactericidal activity, serial dilutions of the incubation mixtures were plated on TH agar, followed by incubation at 37°C overnight, and the number of CFU determined. 100% survival was defined as total survival of bacteria in the same buffer and under the same condition in the absence of peptide.
Antibacterial (30) . Sterile plastic wells were placed in the center of the inoculated areas and 1 ml of 10 mM phosphate buffer, pH 7.4, 0.05 % Triton X-100, added. The skin was scrubbed back and forth for 25 cycles using a sterile blunted, stainless-steel spatula. The liquid was recovered, and the procedure repeated once. The two samples were pooled and CFU determined after appropriate dilutions. For evaluating AMPs ex vivo, a pig skin model was used as previously described (31) but with modifications. Defatted pig hides were first washed with water and then 70% ethanol. They were then destubbed with disposable razors and 8×8 cm pieces were cut, sealed in plastic wrap, and frozen at -20ºC. Before use, the skin samples were thawed, then washed with ethanol (70%) and water. In order to separate the inoculation areas, sterilised tubings (polyethylene, quality 9.6 m, Nalgene ® VWR 228-0170) were cut into ~10 mm lengths, and glued onto the skin samples (cyanoacrylate glue, Henkel, Düsseldorf, Germany). The skin was infected by adding 1x10 6 CFU of an overnight culture of S. aureus ATCC 29213 in a total volume of 10 µl. After an incubation time of 4 hours at 37ºC, peptides containing solutions (0.5 and 1 mM in 100 µl) or the above formulations of GKH17-WWW and as well as ~25 mg control formulation (PEG400/PEG3350/water (54/36/10 w/w) without peptide) were applied. (The formulation without peptide had no bactericidal effect on either S. aureus or E. coli.) Bacterial sampling was then performed after an incubation time of 2 hours by washing the reaction chambers twice with 250 µl of 10 mM Na 2 HPO 4 , pH 7.4, 0.05% Triton X-100, supplemented with 0.1% dextran sulfate (Mw 500 kDa, Sigma-Aldrich, St. Louis, USA), added to block peptide activity during sampling.
Liposome preparation and leakage assayThe liposomes investigated were either zwitterionic (DOPC/cholesterol 60/40 mol/mol or DOPC without cholesterol) or anionic (DOPE/DOPG 75/25 mol/mol). DOPG (1,2-Dioleoyl-sn-Glycero-3-Phosphoglycerol, monosodium salt), DOPC (1,2-dioleoyl-snGlycero-3-phoshocholine), and DOPE (1,2-dioleoyl-sn-Glycero-3-phoshoetanolamine) were all from Avanti Polar Lipids (Alabaster, USA) and of >99% purity, while cholesterol (>99% purity), was from Sigma-Aldrich (St. Louis, USA). Due to the long, symmetric and unsaturated acyl chains of these phospholipids, several methodological advantages are reached. In particular, membrane cohesion is good, which facilitates very stable, unilamellar, and largely defect-free liposomes (observed from cryo-TEM) and well defined supported lipid bilayers (observed by ellipsometry and atomic force microscopy), allowing detailed values on leakage and adsorption density to be obtained. The lipid mixtures were dissolved in chloroform, after which solvent was removed by evaporation under vacuum overnight. Subsequently, 10 mM Tris buffer, pH 7.4, was added together with 0.1 M carboxyfluorescein (CF) (Sigma, St. Louis, USA). After hydration, the lipid mixture was subjected to eight freezethaw cycles consisting of freezing in liquid nitrogen and heating to 60°C. Unilamellar liposomes of about Ø140 nm were generated by multiple extrusions through polycarbonate filters (pore size 100 nm) mounted in a LipoFast miniextruder (Avestin, Ottawa, Canada) at 22°C. Untrapped CF was removed by two subsequent gel filtrations (Sephadex G-50, GE Healthcare, Uppsala, Sweden) at 22°C, with Tris buffer as eluent. CF release from the liposomes was determined by monitoring the emitted fluorescence at 520 nm from a liposome dispersion (10 mM lipid in 10 mM Tris, pH 7.4). An absolute leakage scale was obtained by disrupting the liposomes at the end of each experiment through addition of 0.8 mM Triton X-100 (Sigma-Aldrich, St. Louis, USA). A SPEX-fluorolog 1650 0.22-m double spectrometer (SPEX Industries, Edison, USA) was used for the liposome leakage assay, and also for monitoring W absorption spectra of GKH17-WWW in Tris buffer in the absence and presence of liposomes under conditions described above. Measurements were performed in triplicate at 37 °C.
Dynamic light scattering -The mean hydrodynamic diameter of GKH17 and GKH17-WWW was determined at a peptide concentration of 10 µM in Tris buffer, pH 7.4, by dynamic light scattering at a 173˚ scattering angle, using a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK).
CD-spectroscopy -Circular dichroism (CD) spectra were measured by a Jasco J-810 Spectropolarimeter (Jasco, Easton, USA). The measurements were performed in triplicate at 37°C in a 10 mm quartz cuvette under stirring with a peptide concentration of 10 µM. The effect on peptide secondary structure of liposomes at a lipid concentration of 100 µM was monitored in the range 200-250 nm. To account for instrumental differences between measurements, the background value (detected at 250 nm, where no peptide signal is present) was subtracted. Signals from the bulk solution were also corrected for.
Ellipsometry -Peptide adsorption to supported lipid bilayers was studied in situ by null ellipsometry, using an Optrel Multiskop (Optrel, Kleinmachnow, Germany) equipped with a 100 mW argon laser. All measurements were carried out at 532 nm and an angle of incidence of 67.66° in a 5 ml cuvette under stirring (300 rpm). Both the principles of null ellipsometry and the procedures used have been described extensively before (32) . In brief, by monitoring the change in the state of polarization of light reflected at a surface in the absence and presence of an adsorbed layer, the mean refractive index (n) and layer thickness (d) of the adsorbed layer can be obtained. From the thickness and refractive index the adsorbed amount (Γ) was calculated according to (33) :
where dn/dc is the refractive index increment (0.154 cm 3 /g) (34) and n 0 is the refractive index of the bulk solution. Corrections were routinely done for changes in bulk refractive index caused by changes in temperature and excess electrolyte concentration.
Zwitterionic bilayers were deposited by coadsorption from a mixed micellar solution containing 60/40 mol/mol DOPC/cholesterol and n-dodecyl-β-D-maltoside (DDM; ≥98% purity, Sigma-Aldrich, St. Louis, USA), as described in detail previously (34) . In brief, the mixed micellar solution was formed by addition of 19 mM DDM in water to DOPC/cholesterol dry lipid films, followed by stirring over night, yielding a solution containing 97.3 mol% DDM, 1.6 mol% DOPC and 1.1 mol% cholesterol. This micellar solution was added to the cuvette at 25°C, and the following adsorption monitored as a function of time. When adsorption had stabilised, rinsing with Milli-Q water at 5 ml/min was initiated to remove mixed micelles from solution and surfactant from the substrate. By repeating this procedure and subsequently lowering the concentration of the micellar solution, stable and densely packed bilayers are formed, with structural characteristics similar to those of bulk lamellar structures of the lipids (34) . As sub-bilayer and patchy adsorption resulted from the above mixed micelle approach in the case of the anionic lipid mixture, supported lipid bilayers were generated from liposome adsorption in this case. DOPE/DOPG liposomes (75/25 mol/mol) were prepared as described above, but the dried lipid films resuspended in Tris buffer only with no CF present. In order to avoid adsorption of peptide directly at the silica substrate through any defects of the supported lipid layer, poly-Llysine (M w = 170 kDa, Sigma-Aldrich, St. Louis, USA) was preadsorbed from water prior to lipid addition to an amount of 0.045 ± 0.01 mg/m 2 , followed by removal of nonadsorbed poly-Llysine by rinsing with water at 5 ml/min for 20 minutes. Water in the cuvette was then replaced by buffer containing also 150 mM NaCl, which was followed by addition of liposomes in buffer at a lipid concentration of 20 mM, and subsequently by rinsing with buffer (5 ml/min for 15 minutes) when the liposome adsorption had stabilised. The final layer formed had structural characteristics (thickness 40±10 Å, mean refractive index 1.47±0.026) similar to those of the zwitterionic bilayers, which suggests that a layer fairly close to a complete bilayer is formed. Again, the bilayer build-up was performed at 25°C. After lipid bilayer formation, temperature was raised and the cuvette content replaced by buffer at a rate of 5 ml/min over a period of 30 minutes. After stabilization for 40 minutes, peptide was added to a concentration of 0.01 µM, followed by three subsequent peptide additions to 0.1 µM, 0.5 µM and 1 µM, in all cases monitoring the adsorption for one hour. All measurements were made in at least duplicate.
Slot-blot assay -LPS binding ability of the peptides were examined by slot-blot assay. Peptides (1, 2 and 5 µg) were bound to nitrocellulose membrane (Hybond-C, GE Healthcare BioSciences, UK), pre-soaked in PBS, by vacuum. Membranes were then blocked by 2 wt% BSA in PBS, pH 7.4, for 1 h at RT and subsequently incubated with 125 I-labelled LPS (40 µg/mL; 0.13×10 6 cpm/µg) for 1 h at RT in PBS. After LPS binding, the membranes were washed 3 times, 10 min each time, in PBS and visualized for radioactivity on Bas 2000 radioimaging system (Fuji, Japan).
Statistics -Values are reported as means ± standard deviation of the means. To determine significance, analysis of variance with ANOVA (SigmaStat, SPSS Inc., Chicago, USA), followed by post hoc testing using the Holm-Sidak method, or Student's t-test, were used as indicated in the figure legends, where "n" denotes number of independent experiments. Significance was accepted at p<0.05.
Supplementary data -Supplementary data is available at JBC Online.
RESULTS

Microbicidal potency and proteolytic stability -
Focusing on two kininogen-derived peptides, GKHKNKGKKNGKHNGWK (GKH17) and HKHGHGHGKHKNKGKKN (HKH17) (14) , hydrophobic end-tags were investigated concerning effects of the chemical nature, length, and position of the tags on bactericidal and cytotoxic properties of these peptides. As can be seen in Figure 1A , tagging of GKH17 in both Cand N-termini resulted in enhanced bactericidal effect against Gram-positive S. aureus, an effect increasing with the overall hydrophobicity (35) (36) (37) of the tag. Similar effects were obtained with Gram-negative E. coli, as well as the fungus C. albicans (Supplementary Table 1 ). W-and Ftags emerge as particularly potent, although a spread can be noted, both between microbial isolates and between N-and C-terminal tagging (Supplementary Fig. 1A ). While the initial screening reported in Figure 1A was done in a PEPscreen format, all following experiments were performed for a smaller number of peptides of high (>95%) purity. As above, aliphatic LLL-modifications resulted in substantially weaker antimicrobial effect than the corresponding WWW-modifications (results not shown). Additionally, the bactericidal effect, given by the size of the inhibition zone, increased with the number of W residues in the hydrophobic tag, and was significantly larger than that of the benchmark peptide LL-37 even for a tag consisting of 2W only. For tags consisting of 3W or more, peptides significantly more potent than LL-37 were obtained (Fig.  1B,C) . W-tags also yielded increased activity at physiological salt conditions, particularly noted for the longer tag lengths (Fig. 1C,  Supplementary Fig. 1B ). As shown in Figure 1B , the potentiating effect of the hydrophobic tag can be observed at all peptide concentrations. Extending these investigations also to minimal inhibitory concentration (MIC) for a number of S. aureus (both ATCC and clinical) isolates, Figure 1D shows that WWW-tagging of GKH17 and HKH17 resulted in a broad reduction in MIC values. This was particularly noted for GKH17-WWW, demonstrating MICs significantly lower than those for the benchmark peptide LL-37. Quantitatively, un-tagged GKH17 has a MIC of >80 µM for 8 out of the 9 S. aureus isolates investigated, and of 20 µM for the remaining isolate. For GKH17-WWW, on the other hand, one of these clinical isolates shows a MIC of 0.6 µM, 3 isolates a MIC of 1.2 µM, 3 isolates a MIC of 2.5 µM, and 2 isolates a MIC of 5 µM. As can be seen in Figure 1E , both GKH17 and GKH17-WWW displayed good stability against proteolysis by human leukocyte elastase, as well as staphylococcal aureolysin and V8 proteinase. Similar results were obtained for HKH17 (results not shown). In contrast, and in agreement with previous findings (38) , LL-37 undergoes substantial degradation by all these enzymes. From this it is clear that the stability displayed by GKH17 and HKH17 against proteolytic degradation by HLE, V8, and aureolysin is maintained also after WWW-tagging.
Eukaryotic cell responses -Peptide-induced eukaryotic cell permeabilization was investigated with three different assays to get a broader picture on the potential toxic effects of these peptides. As can be seen in Figure 2 , hydrophobic tagging increased peptide permeabilization of both erythrocytes and human keratinocytes (HaCat) somewhat for short end-tags, an effect increasing substantially with the length of the hydrophobic tag. Quantitatively, the permeabilization in buffer was quite low for tags up to WWW, and significantly lower than that of endogenous LL-37. For the longest tag investigated, WWWWW, permeabilization was comparable to, or lower than, that of LL-37. The toxicity was further reduced, and reaching very low levels for both the tagged peptides and LL-37, in the presence of serum.
Permeabilization of bacteria and liposomesTo learn more about the mechanism behind these observations, a series of experiments was performed. As can be seen in Figure 3A and B, tagging promoted binding of GKH17 to bacteria and subsequent permeabilization. Supplementary  Figure 2A shows that the peptide remained largely disordered on membrane binding, and Supplementary Figure 2B that W tags are located in the proximity of the membrane polar headgroup region. While permeabilization by non-tagged GKH17 was essentially non-observable, it increased strongly with the length of the hydrophobic tag (Fig. 3B) . In parallel, tagged GKH17 caused release of intracellular material of bacteria, similar to LL-37, quantitatively increasing with the length of the hydrophobic tag (Fig. 3A) . In agreement with these findings, the binding of GKH17-WWW was higher than that of GKH17 at model DOPE/DOPE lipid membranes (Fig. 3C) , and peptide-induced leakage from liposomes prepared from the same lipids was dramatically enhanced for GKH17-WWW compared to GKH17 (Fig. 3D) . Also in parallel to bacterial killing, salt resistance of the tagged peptides with respect to liposome leakage induction increased with the length of the hydrophobic tag. In contrast to the anionic and cholesterol-free DOPE/DOPG ("bacterial") membrane, that mimicking eukaryotic cell membranes (DOPC/cholesterol) displayed lower peptide binding, also for the W-tagged peptides, as well as lower liposome leakage induction. In addition to lipid membrane effects, W-tagging facilitated binding to LPS (Supplementary Fig.  2D ), an effect that can be completely reversed through addition of the anionic competitor heparin (results not shown).
Results ex vivo and in vivo in porcine skin infection models -In order to demonstrate the biological relevance of these effects, a series of experiments were performed. Figure 4A shows results on bacterial killing as a function of peptide concentration, both at physiological ionic strength and in the presence of human plasma. As demonstrated, the potentiating effect of the hydrophobic tag remains under these conditions, with GKH17-WWW and GKH17-WWWWW being effective against S. aureus also in the presence of plasma. Furthermore, in an ex vivo porcine skin model, both GKH17-WWW and GKH17-WWWWW showed efficient dose-dependent reduction of S. aureus, with a slightly more efficient bactericidal effect demonstrated for the latter peptide (Fig. 4B,C) . In parallel, efficient and dose-dependent reduction of S. aureus was demonstrated in vivo using a porcine skin infection model, although the presence of competing factors, e.g., related to bacterial re-growth due to incomplete eradication, and presence of scavengers of peptide action, necessitate higher peptide concentrations than those used in vitro (Fig.  4D) .
Concept generalization -Although much of the results presented above have focused on W tagging of GKH17, the concept is applicable also to other hydrophobic tags and other polar and highly charged AMPs. Thus, results similar to those for W were obtained with F tags, showing increasing potency and salt resistance with increasing tag length (Fig. 5A,  Supplementary Fig. 1B) . As with W, F-tagged GKH17 displays very limited toxicity, lower than that of LL-37, particularly in the presence of serum (Fig. 5B and Supplementary Fig. 1C ). Additionally, Figure 5C and Supplementary Figure 1D show that a similar bactericidal effects can be obtained with other peptides as well, demonstrated for GKR22 (GKRKKKGKGLGKKRDPCLRKYK) and PKR 21 (PKRKKKGGKNGKNRRNRKKKN), originating from HB-EGF and amphiregulin, respectively (15) . Similar results were found also for QTP22 (QPTRRPRPGTGPGRRPRPRPRP), derived from PRELP (39), for which QTP22-WWW displayed much higher bactericidal potency than the untagged QTP22 (results not shown). In contrast, hydrophobic end-tagging is not applicable to non-bactericidal peptides. As can be seen in Supplementary Figure 3 , neither of the un-tagged S10 and D10 homopeptides (uncharged and negatively charged, respectively), nor their tagged WWW-variants, displayed any bactericidal effect on E. coli or S. aureus, nor hemolysis above that of the negative control. Neither does the WWW tripeptide tag in the absence of cationic template peptide display any bactericidal effect against E. coli or S. aureus, or cause hemolysis above that of the negative control. Thus, it is the combined effect of W-tagging and the bactericidal properties of the template AMP which underlies activity boosting.
Supplementary data -PEPscreen RDA data on effect of tag composition and location, RDA data on effect of tag length for E. coli, data on cell toxicity for F-tagged peptides, RDA data on GKR22 (-WWW) and PKR21 (-WWW) for E. coli, CD spectra for GKH17 and its W-tagged variants, W fluorescence spectra, dynamic light scattering data, as well as peptide structures, hydrophobicities, and tabulated RDA data for the initial peptide sceening, are available as Supplementary data.
DISCUSSION
This report presents a powerful and generally applicable, practical, and tunable platform based on hydrophobic end-modifications of AMPs. Although such modifications can be designed in a number of ways, end-tagging by hydrophobic amino acid stretches is an attractive alternative since it allows the primary AMP sequence to be retained, at the same time as efficient, but selective, membrane anchoring is achieved. Endtagging also does not affect proteolytic stability of the tagged AMPs detrimentally, a factor of importance for bactericidal potency on S. aureus, P. aeruginosa and other bacteria which secrete AMP-degrading proteases (6) . A number of mechanisms by which AMPs induce membrane defects have been observed. For some peptides, e.g., melittin, alamethicin, magainin 2 and gramicidin A (5,7,40,41), transmembrane structures have been reported, sometimes coupled to peptide self-assembly, although there is some uncertainty on some of these systems (42) . Not rarely, such structures are associated with an ordered secondary structure in the membranebound peptide. For disordered and highly charged peptides, including the ones studied here, membrane disruption is obtained by other mechanisms, e.g., induction of a negative curvature strain, membrane thinning, or local packing defects associated with peptide localization primarily in the phospholipid polar headgroup region (5, (16) (17) (18) (19) 43) . For the latter type of AMPs, defect formation scales with the amount of peptide adsorbed at the lipid membrane, hence reaching a high peptide adsorption at the membrane is a prerequisite for AMP potency (16) (17) (18) (19) . For mechanisms based on peptide adsorption in the proximity of the polar headgroup region of the phospholipid membrane, a high peptide net charge facilitates membrane rupture. Efficient AMPs fulfil both of these criteria, so that a high concentration of electric charges is located at the membrane interface. Although electrostatic interactions provide a driving force for adsorption of positively charged AMPs to highly negatively charged bacterial membranes, these are screened at high ionic strength, resulting in partial or complete loss in bactericidal capacity, e.g., at physiological conditions. Given this, and the ability of S. aureus and other important pathogens to reduce their surface charge density, hydrophobic end-tagging of AMPs may constitute a strategy for improving bactericidal potency of AMPs. Although a number of hydrophobic amino acids may be used as endtags, W-and F-based ones seem to be particularly potent. These bulky and polarizable residues have an affinity to interfaces, and are frequently located in the proximity of the polar headgroup region in phospholipid membranes (44) (45) (46) (47) (48) (49) . In the case of antimicrobial peptides, examples of this have been provided, e.g., by Glukhov et al., who found sequence-dependent penetration of KKKKKKAAXAAWAAXAA (X being W or F) of 2.5-8Å (44) . Similarly, Li et al., investigated aurein 1.2 analogs and found the F residues in these peptides to penetrate 2-5Å below the polar headgroup region (46) . Through this interaction with the phospholipid membrane, W/F residues are able to insert into the membrane, acting as an anchor for the peptide (48, 50) , and resulting in increased bactericidal effects (49, 51, 52) and salt resistance (48) . In contrast to these previous investigations, which report on position-specific single tryptophan substitutions in AMPs, however, the present work describes a generally applicable approach for boosting potency of essentially all (highly charged) AMPs without interfering with the AMP sequence. Thus, various hydrophobic end-tags can be used (W and F being most potent), resulting in efficiency boosting which is largely independent of AMP sequence, while the end-tags themselves, or end-tagged non-AMPs, do not display any bactericidal (nor toxic) effects. In contrast, previous results have shown that peptides based on overall hydrophobic interactions are less selective between bacterial and eukaryotic lipid membranes, resulting in enhanced cytotoxicity of hydrophobic AMPs. For example, peptides composed of L and K only, with a high hydrophobicity/charge ratio (e.g., KLLKLLLKLLKLLLKLLLKLLK) are even more hemolytic than bee venom melittin (4). In comparison, the peptide end-tags investigated here contribute to AMP selectivity between bacterial and eukaryotic membranes. Thus, bacterial membranes are void of cholesterol and rich in anionic phospholipids such as phosphatidyl glycerol, diphosphatidylglycerol, and phosphatidyl serine, while eukaryotic membranes contain cholesterol and are dominated by zwitterionic phospholipids (e.g., phosphatidyl choline). (Although minute lipid component exchange between bacteria and eukaryotic cells in contact during infection cannot be completely excluded, cholesterol content in bacteria membranes is expected to be negligible also under these circumstances.) For a hydrophobic residue to be able to penetrate into the phospholipid membrane, it must overcome the cohesive energy of the latter (53). As cholesterol condenses the phospholipid bilayer and increases its elasticity drastically (25) , end-tagged peptides become sensitive to cholesterol. Particularly for bulky groups such as W and F, which tend to locate in an orientation parallel to the lipid membrane surface, and thus require substantial area expansion (46) , tag insertion into membranes containing cholesterol becomes an energetically costly process. Consequently, the adsorption of tagged peptides is low to cholesterol-containing membranes, as is membrane-induced leakage induction of the corresponding liposomes. This difference in membrane interactions in the presence of absence of cholesterol, together with that due to the charge difference between anionic (ζ ≈ -30 mV) and zwitterionic (ζ ≈ -10 mV) (17) membranes, most likely contributes to the selectivity observed with the presently investigated peptides. For Gramnegative bacteria, this phospholipid membrane selectivity is probably accompanied by selectivity originating from LPS binding, which is significantly enhanced through the W tagging ( Supplementary Fig. 2D) .
Clearly, the end-tagged peptides resemble lipopeptides (20) (21) (22) (23) . The latter consist of a linear or a cyclic peptide sequence of either positive or negative charge, with a hydrophobic moiety, e.g., a fatty acid acid, covalently attached, frequently to the N-terminus of the peptide. Lipopeptides, such as polymyxin B and colistin, are potent against particularly Gram-negative bacteria, although somewhat less so against Gram-positive ones. In parallel, however, these peptides display substantial toxicity, which has restricted their use to local applications, and to severe indications for which other antibiotics are uneffective, e.g., multiresistant P. aeruginosa infections in cystic fibrosis (20) . As for antimicrobial peptides, one of the main targets of lipopeptides is the bacterial membrane (s). Through insertion into the membrane (in the case of daptomycin mediated by Ca 2+ ions (21)), lipopeptides introduce defects, leading to membrane depolarization, reduced ability for ATP synthesis, and many other effects (20) . Particularly closely related to AMPs end-tagged by hydrophobic amino acids stretches are previously investigated cationic peptides conjugated to cholesterol or fatty acids (20) (21) (22) (23) . In analogy to the present findings, elongation of the acyl chain in such lipopeptides resulted in increased membrane disruption in model PG/PE membranes, as well as activity against bacteria and fungi (20) . This may be related to an increased membrane insertion capacity for longer acyl moieties, but may also be an effect of the longer acyl chains promoting lipopeptide oligomerization in a manner similar to that reported by Avrahami and Shai (22) . Interestingly, oligomerization seems to play a key role for these lipopeptides (as for negatively charged daptomycin (21)), while in our case, the W fluorescence spectra show no sign of aggregation for WWW-modified peptides ( Supplementary Fig. 2B ). Thus, the high λ max obtained (360 nm) shows that tryptophan is in contact with the ambient aqueous buffer solution (54). Micelles and other hydrophobically driven self-assemblies, on the other hand, are characterized by very low water content in the self-assembly interior by thermodynamic necessity (24) . In addition, dynamic light scattering of GKH17-WWW shows a narrow peak corresponding to a hydrodynamic diameter of 2 nm, similar to that for un-tagged GKH17 (Supplementary Fig. 2C ). Together, these results show that possible self-assemblies formed in this system (if any) are very small. Thus, aggregation seems not to be required for membrane rupture for these peptides. In analogy to surfactants containing aromatic tails (24) , the bulky and polarizable nature of W and F is expected to preclude self-assembly, resulting in low aggregation numbers, high critical aggregation concentrations, and fast oligomer dissociation kinetics, limiting the relative importance of the aggregated state for membrane insertion and defect formation. Additionally, opposite to several of the previously investigated lipopeptides (e.g., magainin variants), which display helix induction both on interaction with phospholipid membranes and on conjugation of the peptide to the fatty acid moiety, secondary structure induction seems to play little role for the action of the presently investigated peptides. Thus, W-tagging does not induce any ordered secondary structure in GKH17, both the tagged and the non-tagged peptides remaining disordered both in bulk solution and on interaction with anionic liposomes.
As demonstrated, end-tagging by hydrophobic amino acid stretches is a facile and flexible approach of general applicability, by which AMP boosting is obtained for a range of hydrophobic amino acids. It is also applicable for a spectrum of microorganisms, here demonstrated for Grampositive and Gram-negative bacteria, as well as for fungi. Through tag composition and/or length, potency and toxicity can be tuned, e.g., depending on whether the peptide is to be applied in an environment containing serum or not, or depending on the relative need for microbicidal potency and limited toxicity. This flexibility is attractive from a therapeutic perspective, since it allows AMPs to be tagged to fit the conditions of the indication at hand. Particularly for AMPs not sensitive to infection-related proteolysis, the finding that hydrophobic tagging may be achieved without affecting stability against proteolytic degradation, also opens up applications characterized by high proteolytic activity, such as infected wounds, eye infections, and cystic fibrosis. Importantly, hydrophobic tagging may be applied to a broad range of AMPs, particularly polar and highly charged ones. In fact, the approach may possibly also be employed to enhance biological peptide activities in a broader perspective. Although dealing with receptor interactions rather than antimicrobial effects, Ember et al. found that hydrophobic tagging increased the biological potency of short peptide stretches originating from C3a (55). In line with the present findings, peptide potency increased with the number of terminal W residues, W being more efficient than I in increasing peptide biological activity. Although membrane interactions played a role, W-tagging notably promoted specific peptide binding to the C3a receptor. End-tagging by hydrophobic amino acid stretches may thus potentially offer a way to promote also more specific peptide docking and functions. Figure 1A are 0.583 and 0.340, respectively, for the N-terminal modifications, and 0.881 and 0.776, respectively, for the C-terminal modifications.) (B) Dose dependent activity of the selected peptides GKH17 and HKH17 and WWW-tagged variants against S. aureus (4x10 6 CFU) in RDA. (The difference between the original peptides GKH17, HKH17 and their tagged variants is significant (P < 0.05, two way ANOVA).) (C) Effect of tag length on GKH17 peptide activity (at 50 µM) against S. aureus ATCC 29213 as assessed by RDA in the presence and absence of 0.15 M NaCl. "*" denotes no detectable clearance zone. (In absence of salt the difference between all tagged peptides and no tag is significant. In presence of 0.15 M NaCl, the difference between the WWW and WWWWW peptides vs no tag is significant (P < 0.05, one way ANOVA).) (D) Minimal inhibitory concentrations (MIC) of indicated peptides against different S. aureus isolates. (E) Protease sensitivity of peptides. The indicated peptides were incubated with (+) or without (-) the S. aureus enzymes aureolysin (Aur), V8 proteinase (V8), or human leukocyte elastase (HLE) and analyzed by SDS-PAGE (16.5% Tris-Tricine gels).
Fig. 2. Activities of peptides against eukaryotic cells. (A)
Effects of peptides on HaCaT cells and erythrocytes in absence of human serum. The MTT-assay (upper panel) was used to measure viability of HaCaT keratinocytes in the presence of GKH17 peptides with variable W tagging. In the assay, MTT is modified into a dye, blue formazan, by enzymes associated with metabolic activity. The absorbance of the dye was measured at 550 nm. Cell permeabilizing effects of the indicated peptides (middle panel) were measured by the LDH based TOX-7 kit. Hemolytic effects (lower panel) of the indicated GKH17 variant peptides were investigated, and corresponding data for LL-37 included for comparison. The cells were incubated with the peptides at 60 µM, and 2% Triton X-100 served as positive control. The absorbance of hemoglobin release was measured at 540 nm and is expressed as % of Triton X-100 induced hemolysis (note scale of y-axis). (MTT: The difference between the WWW and longer variant peptides vs no tag is significant (P < 0.05, one way ANOVA); LDH: The difference between the WWW and longer variant peptides vs no tag is significant (P < 0.05, one way ANOVA); Hemolysis: The difference between the WWWWW variant vs no tag is significant (P < 0.05, one way ANOVA). (B) Effects of GKH17 and W-modified variants in presence of human serum. Identical experiments as in (A) were performed in presence of human 20% serum. For assessment of hemolysis in presence of serum, only those peptides displaying significant hemolytic activities in absence of serum were analysed. (MTT: There is no significant difference between the peptide variants; LDH: The difference between the WWWWW variant peptide vs. no tag is significant (P < 0.05, one way ANOVA); Hemolysis: There is no significant difference between the peptide variants.) (There is a statistically significant difference (P <0.001 two way ANOVA) between the tagged peptides vs. control as well as the native peptide (no tag) at the two doses.) (C) Inoculation similar as in (B), but pig skin was treated with GKH17 and GKH17-WWW (2.8 mM) in a polyethylene glycol formulation (PEG400/PEG3350/water 54/36/10). (There is a statistically significant difference between control treatment and WWW (P <0.001, students t-test).) (D) Treatment of S. aureus infected pig skin in vivo. Treatment with GKH17-WWW at two concentrations in a polyethylene glycol formulation (PEG400/PEG3350/water 54/36/10), and with formulation in the absence of peptide (2.8 and 5.6 mM). (There is a statistically significant difference between control treatment and the two concentrations of WWW (P < 0.05, one way ANOVA).) 
